We are live on ! Find out more
LAB icon

Standard BioTools
LAB

84 hedge funds and large institutions have $217M invested in Standard BioTools in 2018 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 38 increasing their positions, 18 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 18

33% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 9

4% more funds holding

Funds holding: 81 → 84 (+3)

5% more call options, than puts

Call options by funds: $238K | Put options by funds: $227K

0.42% more ownership

Funds ownership: 95.01% → 95.42% (+0.42%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% less capital invested

Capital invested by funds: $217M → $217M (-$852K)

Holders
84
Holders Change
+3
Holders Change %
+3.7%
% of All Funds
1.93%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
38
Reduced
18
Closed
9
Calls
$238K
Puts
$227K
Net Calls
+$11K
Net Calls Change
+$28K

Top Buyers

1
LCS
Levin Capital Strategies
New York
+$3.6M
2
Millennium Management
Millennium Management
New York
+$2.45M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$1.02M
4
SSA
Schonfeld Strategic Advisors
New York
+$982K
5
Renaissance Technologies
Renaissance Technologies
New York
+$965K

Top Sellers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$7.65M
2
Neuberger Berman Group
Neuberger Berman Group
New York
-$1.47M
3
WA
Wasatch Advisors
Utah
-$1.3M
4
SAM
Silverback Asset Management
North Carolina
-$953K
5
Russell Investments Group
Russell Investments Group
United Kingdom
-$795K
Name Holding Trade Value Shares
Change 		Change in
Stake
LCS
1
Levin Capital Strategies
New York
$56.7M +$3.6M +548,338 +6%
Primecap Management
2
Primecap Management
California
$33.8M +$78.1K +11,900 +0.2%
Neuberger Berman Group
3
Neuberger Berman Group
New York
$26.4M -$1.47M -223,774 -5%
Russell Investments Group
4
Russell Investments Group
United Kingdom
$21.7M -$795K -121,070 -3%
BlackRock
5
BlackRock
New York
$12.9M +$183K +27,881 +1%
O
6
OrbiMed
New York
$9.25M – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$7.81M +$82.4K +12,545 +0.9%
Renaissance Technologies
8
Renaissance Technologies
New York
$5.56M +$965K +147,000 +18%
State Street
9
State Street
Massachusetts
$3.51M +$334K +50,920 +9%
PAM
10
Panagora Asset Management
Massachusetts
$3.01M +$760K +115,727 +29%
Northern Trust
11
Northern Trust
Illinois
$2.74M +$16.2K +2,461 +0.5%
HVC
12
Healthcare Value Capital
New Jersey
$2.4M – – –
Bank of New York Mellon
13
Bank of New York Mellon
New York
$2.33M +$96.6K +14,708 +4%
Millennium Management
14
Millennium Management
New York
$2.29M +$2.45M +373,673 +2,126%
Acadian Asset Management
15
Acadian Asset Management
Massachusetts
$1.76M +$1.02M +154,678 +105%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$1.5M +$28.9K +4,406 +2%
Jacobs Levy Equity Management
17
Jacobs Levy Equity Management
New Jersey
$1.43M +$28.2K +4,300 +2%
Fuller & Thaler Asset Management
18
Fuller & Thaler Asset Management
California
$1.27M -$110K -16,700 -7%
Goldman Sachs
19
Goldman Sachs
New York
$1.14M -$63.8K -9,713 -5%
Connor, Clark & Lunn Investment Management (CC&L)
20
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.1M +$289K +43,950 +30%
AC
21
Alexandria Capital
Virginia
$1.1M – – –
BCM
22
Bridgeway Capital Management
Texas
$984K +$624K +95,000 +129%
WMSA
23
Weiss Multi-Strategy Advisers
New York
$964K +$164K +25,000 +18%
Norges Bank
24
Norges Bank
Norway
$959K – – –
Morgan Stanley
25
Morgan Stanley
New York
$901K +$491K +74,708 +94%
1
2 3 4

LAB Hedge Fund Activity: Q1 2018 in Review

84 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q1 2018, worth a combined $217M — down 0.39% from $217M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new LAB positions and 9 closed out — a net gain of 3 holders — while 38 added to existing stakes and 18 trimmed.

The largest buyer was Levin Capital Strategies, adding an estimated $3.6M. The largest seller was Adage Capital Partners, cutting an estimated $7.65M.

  • 84 institutional investors held Standard BioTools (LAB) as of Q1 2018, up from 81 in Q4 2017.
  • Funds reported $217M of Standard BioTools stock for Q1 2018, down 0.39% quarter-over-quarter.
  • 12 funds opened new Standard BioTools positions in Q1 2018 and 9 closed out, a net change of +3 holders.
  • The largest Standard BioTools buyer in Q1 2018 was Levin Capital Strategies, an estimated $3.6M added.
  • The largest Standard BioTools seller in Q1 2018 was Adage Capital Partners, an estimated $7.65M sold.

Based on aggregated 13F filings for Q1 2018.